0QNZ.LSE CPH Chemie + Papier Holding AG
- Market cap
- GBP 5.28M
- P/E
- -
- P/B
- -
- ROE
- 27.1%
- Dividend yield
- 0.03%
- Fundamental score
- -
Ratios use the latest price and the current fiscal year annualized from 1 quarter up to Jun 2026.
Is 0QNZ.LSE undervalued?
Graham numberThe Graham number of CPH Chemie + Papier Holding AG cannot be estimated reliably (it needs positive earnings and book value).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
CPH Chemie + Papier Holding AG fundamental analysis
No fundamental analysis for CPH Chemie + Papier Holding AG yet.
CPH Chemie + Papier Holding AG stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About CPH Chemie + Papier Holding AG
CPH Group AG, together with its subsidiaries, develops, manufactures, and distributes chemical products and packaging solutions for pharmaceutical customers in Europe, Asia, and North and South America. It operates through two segments: Zeochem and Perlen Packaging. The Zeochem segment produces molecular sieves for industrial and medical applications, chromatography gels for the pharmaceutical industry, and deuterated products used in analytics, pharmaceuticals, and OLED dis…
Full company profileCPH Chemie + Papier Holding AG financial statements
2026 annualized: Fiscal year 2026 is not finished. Income statement and cash flow are annualized from 1 quarter up to Jun 30, 2026, the balance sheet is the latest quarter. Figures change when the annual report is published.
CPH Chemie + Papier Holding AG annual financial statements
| Item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 Anlz |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | |||||||||||
| Revenue | 435M | 470M | 534M | 525M | 445M | 497M | 725M | 624M | 448M | 334M | 704M |
| Gross Profit | 24.7M | 24.2M | 73.1M | 77.1M | 43.8M | -2.92M | 125M | 225M | 57.3M | 62.5M | 140M |
| Operating Income | -76.0K | -499K | 47.5M | 51.7M | 19.7M | -26.8M | 91.5M | 82.8M | 30.0M | 32.8M | 75.9M |
| EBITDA | 32.7M | 54.8M | 82.8M | 88.1M | 72.3M | -118M | 122M | 113M | 31.5M | 50.3M | 113M |
| Net Income | -7.91M | 16.0M | 42.3M | 48.3M | 46.9M | -152M | 101M | 78.9M | 4.65M | 23.4M | 57.0M |
| EPS | -1.32 | 2.66 | 7.05 | 8.06 | 7.82 | -25 | 17 | 13 | 0.78 | 3.90 | 9.51 |
| Balance Sheet | |||||||||||
| Total Assets | 672M | 698M | 800M | 703M | 704M | 560M | 666M | 598M | 333M | 369M | 393M |
| Total Liabilities | 292M | 301M | 393M | 261M | 232M | 250M | 267M | 162M | 123M | 165M | 183M |
| Shareholders' Equity | 378M | 393M | 405M | 440M | 471M | 309M | 398M | 436M | 209M | 204M | 210M |
| Cash & Short-term Investments | 70.4M | 80.2M | 89.0M | 93.1M | 116M | 95.1M | 144M | 108M | 31.6M | 27.0M | 33.0M |
| Total Debt | 153M | 153M | 246M | 123M | 118M | 110M | 98.9M | 723K | 18.9M | 53.2M | 58.4M |
| Cash Flow | |||||||||||
| Operating Cash Flow | 21.9M | 32.2M | 64.3M | 61.0M | 55.0M | 15.8M | 97.6M | 110M | 45.7M | 34.1M | 83.8M |
| Capital Expenditure | 22.0M | 34.7M | 24.5M | 22.9M | 18.8M | 24.6M | 33.9M | 33.8M | 21.6M | 18.9M | 32.7M |
| Free Cash Flow | -87.0K | -2.54M | 39.8M | 38.2M | 36.2M | -8.76M | 63.7M | 76.1M | 24.1M | 15.2M | 51.0M |
| Ratios | |||||||||||
| ROE | -2.1% | 4.1% | 10.4% | 11.0% | 10.0% | -49.0% | 25.4% | 18.1% | 2.2% | 11.5% | 27.1% |
| ROA | -1.2% | 2.3% | 5.3% | 6.9% | 6.7% | -27.0% | 15.2% | 13.2% | 1.4% | 6.3% | 14.5% |
| Net Profit Margin | -1.8% | 3.4% | 7.9% | 9.2% | 10.5% | -30.5% | 13.9% | 12.6% | 1.0% | 7.0% | 8.1% |
| Debt to Equity | 0.40x | 0.39x | 0.61x | 0.28x | 0.25x | 0.36x | 0.25x | 0.00x | 0.09x | 0.26x | 0.28x |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Total Debt
- Short and long-term borrowings.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
- Debt to Equity
- Total debt divided by shareholders' equity.
CPH Chemie + Papier Holding AG dividends
- Dividend yield
- 0.03%
- Forward dividend
- -
- Payout ratio
- 51.4%
- Ex-dividend date
- -
| Fiscal year | Dividends paid | Per share | Payout ratio |
|---|---|---|---|
| 2025 | 12.0M | 2.00 | 51.4% |
| 2024 | CHF 24.0M | 4.00 | 516.4% |
| 2023 | CHF 27.0M | 4.50 | 34.2% |
| 2022 | CHF 7.80M | 1.30 | 7.7% |
| 2021 | GBP 10.8M | 1.80 | - |
| 2020 | GBP 16.0K | 0.00 | 0.0% |
| 2019 | GBP 10.8M | 1.80 | 22.3% |
| 2018 | GBP 3.90M | 0.65 | 9.2% |
| 2017 | GBP 3.90M | 0.65 | 24.4% |
From the cash flow statement: dividends paid in the fiscal year, divided by that year's shares outstanding. Payout ratio = dividends paid / net income.
Who owns CPH Chemie + Papier Holding AG
- Insiders 38.29%
- Institutions 12.44%
- Public & others 49.28%
- Shares outstanding 5.99M
- Free float 2.82M
CPH Chemie + Papier Holding AG company profile
- Company name
- CPH Chemie + Papier Holding AG
- Ticker
- 0QNZ.LSE
- ISIN
- CH0001624714
- Exchange
- London Exchange
- Sector
- Basic Materials
- Industry
- Oil, Gas & Consumable Fuels
- Employees
- 1,249
- Fiscal year end
- December
- Address
- Perlenring 1, Perlen, Switzerland, 6035
- Phone
- 41 41 455 87 67
- Website
- cph.ch
About CPH Chemie + Papier Holding AG
CPH Group AG, together with its subsidiaries, develops, manufactures, and distributes chemical products and packaging solutions for pharmaceutical customers in Europe, Asia, and North and South America. It operates through two segments: Zeochem and Perlen Packaging. The Zeochem segment produces molecular sieves for industrial and medical applications, chromatography gels for the pharmaceutical industry, and deuterated products used in analytics, pharmaceuticals, and OLED displays. This segment also operates production facilities in Switzerland, Bosnia and Herzegovina, the USA, Canada, China, and India. The Perlen Packaging segment focuses on the pharmaceutical industry, supplying coated plastic films used primarily in blister packaging to protect medications, as well as vials and containers for medical use; and PVC mono films and coated PVdC barrier films for use in the pharmaceutical industry. CPH Group AG was founded in 1818 and is based in Perlen, Switzerland.
CPH Chemie + Papier Holding AG management
3- Dr. Alois Waldburg-ZeilGroup CEO & Head of Zeochem · born 1963
- Mr. Gerold Brütsch CPAChief Financial Officer · born 1966
- Mr. Marc HallerHead of Packaging Division · born 1970